send link to app

Sharpen Family


4.6 ( 8336 ratings )
Gesundheit und Fitness Bildung
Entwickler Resiliency Technologies
Frei

Sharpen is a content creation and delivery platform with a closed social network. We help health providers and mission driven organizations increase outreach and compliance with their constituents. We specialize in mental health and provide end-users with education and interactive tools to increase resiliency and overall mental wellbeing.

Access to SharpenFAMILY is provided through a group of mobile apps targeted to serve different audience types and tailored to address the specific needs of the foster care community. SharpenFAMILY provides a host of life-saving educational tools to teach about strategies for navigating the foster care system, early childhood development and connections to resources in the community. The platform also connects families to a library of skills building content designed from 8 scientific protective factors for resiliency. Most importantly, SharpenFAMILY engages parents and foster children into a personal dialogue with other peers and specialists, guiding them to the rich resources of the United Way of the Piedmont.

The cutting-edge technology behind SharpenFAMILY ensures more families and children receive the services they need. Our powerful data gathering tools give you the information to make a real impact in your community. Through both mobile apps and a desktop platform, SharpenFAMILY delivers evidence-based educational content to targeted audiences, identifies individuals who may be suffering from mental health conditions and safely connects them to appropriate levels of treatment.

The Sharpen system has undergone testing in collaboration with researchers in public health and psychology for over 11 years. In addition, SharpenFAMILY is currently being piloted with research evaluation teams from Costal Carolina University, VCOM College of Osteopathic Medicine, and USC Upstate. Our medical advisory team includes two child and adolescent psychiatrists and a number of PhD clinicians.